Drug profile · INN
hydroxychloroquine
APO- HYDROXYCHLOROQUINE
hydroxychloroquine (APO- HYDROXYCHLOROQUINE) is a toll-like receptor 7 antagonist. Associated with Sanofi-aventis Healthcare Pty Ltd.
TGA: approved NMPA: clinical trials
Patents linked 0
Pipeline programs 14
News articles 0
Drug details — hydroxychloroquine
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 14
- Data quality
- 0.81
Quick answer
hydroxychloroquine (APO- HYDROXYCHLOROQUINE) is a toll-like receptor 7 antagonist. Associated with Sanofi-aventis Healthcare Pty Ltd.
Key facts
INN hydroxychloroquine
Brand APO- HYDROXYCHLOROQUINE
Mechanism Toll-like receptor 7 antagonist
Originator Sanofi-aventis Healthcare Pty Ltd
Mechanism of action
Toll-like receptor 7 antagonist
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
| NMPA | clinical trials | — |
Pipeline programs
Frequently asked questions
What is hydroxychloroquine?
hydroxychloroquine (APO- HYDROXYCHLOROQUINE) is a toll-like receptor 7 antagonist. Associated with Sanofi-aventis Healthcare Pty Ltd.
What is the brand name for hydroxychloroquine?
APO- HYDROXYCHLOROQUINE is a marketed brand name for hydroxychloroquine. Check FDA Drugs@FDA for the current US label holder and prescribing information.